BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 28385827)

  • 1. Lesion location and cognitive impact of cerebral small vessel disease.
    Biesbroek JM; Weaver NA; Biessels GJ
    Clin Sci (Lond); 2017 Apr; 131(8):715-728. PubMed ID: 28385827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Strategically Located White Matter Hyperintensities on Cognition in Memory Clinic Patients with Small Vessel Disease.
    Biesbroek JM; Weaver NA; Hilal S; Kuijf HJ; Ikram MK; Xu X; Tan BY; Venketasubramanian N; Postma A; Biessels GJ; Chen CP
    PLoS One; 2016; 11(11):e0166261. PubMed ID: 27824925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.
    Molad J; Kliper E; Korczyn AD; Ben Assayag E; Ben Bashat D; Shenhar-Tsarfaty S; Aizenstein O; Shopin L; Bornstein NM; Auriel E
    J Alzheimers Dis; 2017; 56(4):1293-1299. PubMed ID: 28157096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL.
    Duering M; Zieren N; Hervé D; Jouvent E; Reyes S; Peters N; Pachai C; Opherk C; Chabriat H; Dichgans M
    Brain; 2011 Aug; 134(Pt 8):2366-75. PubMed ID: 21764819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline predictors of cognitive decline in patients with cerebral small vessel disease.
    Pavlovic AM; Pekmezovic T; Tomic G; Trajkovic JZ; Sternic N
    J Alzheimers Dis; 2014; 42 Suppl 3():S37-43. PubMed ID: 24898641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Covariance Networks and Their Association with Age, Features of Cerebral Small-Vessel Disease, and Cognitive Functioning in Older Persons.
    Foster-Dingley JC; Hafkemeijer A; van den Berg-Huysmans AA; Moonen JE; de Ruijter W; de Craen AJ; van der Mast RC; Rombouts SA; van der Grond J
    Brain Connect; 2016 Nov; 6(9):681-690. PubMed ID: 27506114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain atrophy and strategic lesion location increases risk of parkinsonism in cerebral small vessel disease.
    Bergkamp MI; Tuladhar AM; van der Holst HM; van Leijsen EMC; Ghafoorian M; van Uden IWM; van Dijk EJ; Norris DG; Platel B; Esselink RAJ; Leeuw FE
    Parkinsonism Relat Disord; 2019 Apr; 61():94-100. PubMed ID: 30448096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter integrity in small vessel disease is related to cognition.
    Tuladhar AM; van Norden AG; de Laat KF; Zwiers MP; van Dijk EJ; Norris DG; de Leeuw FE
    Neuroimage Clin; 2015; 7():518-24. PubMed ID: 25737960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral Microbleeds and White Matter Hyperintensities are Associated with Cognitive Decline in an Asian Memory Clinic Study.
    Gyanwali B; Lui B; Tan CS; Chong EJY; Vrooman H; Chen C; Hilal S
    Curr Alzheimer Res; 2021; 18(5):399-413. PubMed ID: 34420506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High white matter hyperintensity burden in strategic white matter tracts relates to worse global cognitive performance in community-dwelling individuals.
    Biesbroek JM; Lam BYK; Zhao L; Tang Y; Wang Z; Abrigo J; Chu WWC; Wong A; Shi L; Kuijf HJ; Biessels GJ; Mok VCT
    J Neurol Sci; 2020 Jul; 414():116835. PubMed ID: 32330699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral Perfusion and the Burden of Small Vessel Disease in Patients Referred to a Memory Clinic.
    Onkenhout L; Appelmans N; Kappelle LJ; Koek D; Exalto L; de Bresser J; Biessels GJ;
    Cerebrovasc Dis; 2020; 49(5):481-486. PubMed ID: 33075786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
    Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
    Front Immunol; 2021; 12():803504. PubMed ID: 34956241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for and Clinical Relevance of Incident and Progression of Cerebral Small Vessel Disease Markers in an Asian Memory Clinic Population.
    Gyanwali B; Shaik MA; Tan BY; Venketasubramanian N; Chen C; Hilal S
    J Alzheimers Dis; 2019; 67(4):1209-1219. PubMed ID: 30714960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total cerebral small vessel disease score and cognitive performance in community-dwelling older adults. Results from the Atahualpa Project.
    Del Brutto VJ; Ortiz JG; Del Brutto OH; Mera RM; Zambrano M; Biller J
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):325-331. PubMed ID: 28548298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric Correlates of Small Vessel Disease Progression in Incident Cognitive Decline: Independent and Interactive Effects.
    Kan CN; Gyanwali B; Hilal S; Ng KP; Venketasubramanian N; Chen CL; Xu X
    J Alzheimers Dis; 2020; 73(3):1053-1062. PubMed ID: 31884482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using DTI to assess white matter microstructure in cerebral small vessel disease (SVD) in multicentre studies.
    Croall ID; Lohner V; Moynihan B; Khan U; Hassan A; O'Brien JT; Morris RG; Tozer DJ; Cambridge VC; Harkness K; Werring DJ; Blamire AM; Ford GA; Barrick TR; Markus HS
    Clin Sci (Lond); 2017 Jun; 131(12):1361-1373. PubMed ID: 28487471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline characteristic of patients presenting with lacunar stroke and cerebral small vessel disease may predict future development of depression.
    Pavlovic AM; Pekmezovic T; Zidverc Trajkovic J; Svabic Medjedovic T; Veselinovic N; Radojicic A; Mijajlovic M; Tomic G; Jovanovic Z; Norton M; Sternic N
    Int J Geriatr Psychiatry; 2016 Jan; 31(1):58-65. PubMed ID: 25821003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of acute infarcts to cerebral small vessel disease progression.
    Ter Telgte A; Wiegertjes K; Gesierich B; Marques JP; Huebner M; de Klerk JJ; Schreuder FHBM; Araque Caballero MA; Kuijf HJ; Norris DG; Klijn CJM; Dichgans M; Tuladhar AM; Duering M; de Leeuw FE
    Ann Neurol; 2019 Oct; 86(4):582-592. PubMed ID: 31340067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical associations of T2-weighted lesion load and lesion location in small vessel disease: Insights from a large prospective cohort study.
    Altermatt A; Gaetano L; Magon S; Bauer L; Feurer R; Gnahn H; Hartmann J; Seifert CL; Poppert H; Wuerfel J; Radue EW; Kappos L; Sprenger T
    Neuroimage; 2019 Apr; 189():727-733. PubMed ID: 30685330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategic lacunes and their relationship to cognitive impairment in cerebral small vessel disease.
    Benjamin P; Lawrence AJ; Lambert C; Patel B; Chung AW; MacKinnon AD; Morris RG; Barrick TR; Markus HS
    Neuroimage Clin; 2014; 4():828-37. PubMed ID: 24936433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.